Clinical trial of a genetically modified Herpes virus for the treatment of cystic fibrosis
We want you to understand and use our information whatever your level of ability or background. To do this we follow web standards and provide documents in different formats. You can even listen to our website or contact us for more help.
This Communiqué covers matters considered at the 32nd videoconference of the Gene Technology Technical Advisory Committee (12 September 2022).
This issue focuses on what we mean by intentional release as well as providing information about the new clinical trial licence application form.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2021-22.
Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2022.
Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2022.
All dealings with a genetically modified organism must be approved. Find out what a dealing is and how to get, and maintain, approval.
You may need authorisation to work with genetically modified organisms (GMOs). Find out what is involved.
Accreditation is often a licence requirement. All organisations dealing with genetically modified organisms should consider accreditation. Find out more about accreditation.